Researchers claim compound has potential to slow Huntington's disease
A compound that has the ability to reduce oxidative damage has the potential to slow the progression of Huntington's disease, according to a new study.
Researchers at the University of Rochester Medical Centre claim that Coenzyme Q10 (CoQ) acts as an antioxidant in patients with Huntington's disease and requires further study.
Dr Kevin M Biglan, lead author of the study, also stresses that the discovery enables scientists to better evaluate the potential of new treatments by identifying a new biomarker for neurological conditions.
The efficacy of CoQ was identified when researchers evaluated the blood samples of 20 people with Huntington's disease who had undergone treatment with CoQ in a previous clinical trial.
It was observed that in addition to improving the appearance of some symptoms of the condition, it had an effect on a molecular level in the brain, dropping the levels of a genetic code malfunction known to cause Huntington's by 20 per cent.
The findings coincide with the announcement that a new device implanted in the brains of those with Huntington's disease could have a restorative effect for patients. However, further testing is needed.
Find out how Barchester works to create safe and understanding environments for those living with Huntington's Disease.
Find your nearest Barchester care home
With over 200 care homes in the UK, there's always a Barchester care home near you.